ID   LANM_METEA              Reviewed;         133 AA.
AC   C5B164;
DT   24-JUL-2024, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 1.
DT   09-APR-2025, entry version 100.
DE   RecName: Full=Lanmodulin {ECO:0000303|PubMed:30351021, ECO:0000303|PubMed:30352145};
DE            Short=LanM {ECO:0000303|PubMed:30351021, ECO:0000303|PubMed:30352145};
DE   AltName: Full=Lanthanide-binding protein {ECO:0000303|PubMed:30351021};
DE            Short=Ln(3+)-binding protein {ECO:0000303|PubMed:30351021};
DE   Flags: Precursor;
GN   Name=lanM {ECO:0000303|PubMed:30351021};
GN   OrderedLocusNames=MexAM1_META1p1786 {ECO:0000312|EMBL:ACS39628.1};
OS   Methylorubrum extorquens (strain ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB
OS   9133 / AM1) (Methylobacterium extorquens).
OC   Bacteria; Pseudomonadati; Pseudomonadota; Alphaproteobacteria;
OC   Hyphomicrobiales; Methylobacteriaceae; Methylorubrum.
OX   NCBI_TaxID=272630;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1;
RX   PubMed=19440302; DOI=10.1371/journal.pone.0005584;
RA   Vuilleumier S., Chistoserdova L., Lee M.-C., Bringel F., Lajus A., Zhou Y.,
RA   Gourion B., Barbe V., Chang J., Cruveiller S., Dossat C., Gillett W.,
RA   Gruffaz C., Haugen E., Hourcade E., Levy R., Mangenot S., Muller E.,
RA   Nadalig T., Pagni M., Penny C., Peyraud R., Robinson D.G., Roche D.,
RA   Rouy Z., Saenampechek C., Salvignol G., Vallenet D., Wu Z., Marx C.J.,
RA   Vorholt J.A., Olson M.V., Kaul R., Weissenbach J., Medigue C.,
RA   Lidstrom M.E.;
RT   "Methylobacterium genome sequences: a reference blueprint to investigate
RT   microbial metabolism of C1 compounds from natural and industrial sources.";
RL   PLoS ONE 4:E5584-E5584(2009).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION, MASS
RP   SPECTROMETRY, SUBUNIT, AND MUTAGENESIS OF PRO-36; PRO-60; PRO-85 AND
RP   PRO-109.
RC   STRAIN=ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1;
RX   PubMed=30351021; DOI=10.1021/jacs.8b09842;
RA   Cotruvo J.A. Jr., Featherston E.R., Mattocks J.A., Ho J.V., Laremore T.N.;
RT   "Lanmodulin: A Highly Selective Lanthanide-Binding Protein from a
RT   Lanthanide-Utilizing Bacterium.";
RL   J. Am. Chem. Soc. 140:15056-15061(2018).
RN   [3]
RP   BIOTECHNOLOGY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=32686425; DOI=10.1021/acs.inorgchem.0c01303;
RA   Deblonde G.J., Mattocks J.A., Park D.M., Reed D.W., Cotruvo J.A. Jr.,
RA   Jiao Y.;
RT   "Selective and Efficient Biomacromolecular Extraction of Rare-Earth
RT   Elements using Lanmodulin.";
RL   Inorg. Chem. 59:11855-11867(2020).
RN   [4] {ECO:0007744|PDB:6MI5}
RP   STRUCTURE BY NMR OF 23-133 IN COMPLEX WITH Y(3+).
RC   STRAIN=ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1;
RX   PubMed=30352145; DOI=10.1021/acs.biochem.8b01019;
RA   Cook E.C., Featherston E.R., Showalter S.A., Cotruvo J.A.;
RT   "Structural Basis for Rare Earth Element Recognition by Methylobacterium
RT   extorquens Lanmodulin.";
RL   Biochemistry 58:120-125(2019).
RN   [5] {ECO:0007744|PDB:8FNS}
RP   X-RAY CRYSTALLOGRAPHY (1.01 ANGSTROMS) OF 29-133 IN COMPLEX WITH ND(3+).
RC   STRAIN=ATCC 14718 / DSM 1338 / JCM 2805 / NCIMB 9133 / AM1;
RX   PubMed=37259003; DOI=10.1038/s41586-023-05945-5;
RA   Mattocks J.A., Jung J.J., Lin C.Y., Dong Z., Yennawar N.H.,
RA   Featherston E.R., Kang-Yun C.S., Hamilton T.A., Park D.M., Boal A.K.,
RA   Cotruvo J.A.;
RT   "Enhanced rare-earth separation with a metal-sensitive lanmodulin dimer.";
RL   Nature 618:87-93(2023).
CC   -!- FUNCTION: High-affinity lanthanide (Ln)-binding protein. Shows 100
CC       million-fold selectivity for La(3+) over Ca(2+). Binds 3 equiv of
CC       Ln(3+) with picomolar affinity and a fourth with approximately
CC       micromolar affinity. May be involved in receiving and then transporting
CC       lanthanides (such as La(3+), Nd(3+) and Sm(3+)) to a specific
CC       periplasmic destination. {ECO:0000269|PubMed:30351021}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         REE-LanM complexes are remarkably resilient under acidic conditions,
CC         retaining REE binding down to pH 2.5. {ECO:0000269|PubMed:32686425};
CC       Temperature dependence:
CC         REE-LanM complexes are stable over a broad temperature range (up to
CC         95 degrees Celsius). {ECO:0000269|PubMed:32686425};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:30351021}.
CC   -!- SUBCELLULAR LOCATION: Periplasm {ECO:0000305|PubMed:30351021}.
CC   -!- MASS SPECTROMETRY: Mass=11759.574; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:30351021};
CC   -!- BIOTECHNOLOGY: Has been used for metal extraction from two distinct
CC       rare-earth elements (REEs)-containing industrial feedstocks covering a
CC       broad range of REE and non-REE concentrations, namely, precombustion
CC       coal (lignite) and electronic waste leachates. After only a single all-
CC       aqueous step, quantitative and selective recovery of the REEs from all
CC       non-REEs initially present (Li, Na, Mg, Ca, Sr, Al, Si, Mn, Fe, Co, Ni,
CC       Cu, Zn, and U) was achieved, demonstrating the universal selectivity of
CC       LanM for REEs against non-REEs and its potential application even for
CC       industrial low-grade sources. {ECO:0000269|PubMed:32686425}.
CC   -!- MISCELLANEOUS: Lanthanides are essential cofactors in some
CC       pyrroloquinoline quinone (PQQ)-dependent alcohol dehydrogenase enzymes
CC       in the methylotrophic bacterium M.extorquens. {ECO:0000305}.
CC   -!- MISCELLANEOUS: LanM undergoes a large conformational change from a
CC       largely disordered state to a compact, ordered state, selectively in
CC       response to picomolar concentrations of all Ln(3+) (Ln = La-Lu) and
CC       Y(3+). {ECO:0000269|PubMed:30351021}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP001510; ACS39628.1; -; Genomic_DNA.
DR   RefSeq; WP_003601797.1; NC_012808.1.
DR   PDB; 6MI5; NMR; -; X=23-133.
DR   PDB; 8FNS; X-ray; 1.01 A; A=29-133.
DR   PDBsum; 6MI5; -.
DR   PDBsum; 8FNS; -.
DR   AlphaFoldDB; C5B164; -.
DR   BMRB; C5B164; -.
DR   SMR; C5B164; -.
DR   STRING; 272630.MexAM1_META1p1786; -.
DR   KEGG; mea:Mex_1p1786; -.
DR   eggNOG; COG5126; Bacteria.
DR   HOGENOM; CLU_091273_5_0_5; -.
DR   OrthoDB; 8453759at2; -.
DR   Proteomes; UP000009081; Chromosome.
DR   GO; GO:0042597; C:periplasmic space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF13202; EF-hand_5; 3.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Metal-binding; Periplasm; Reference proteome; Repeat; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:30351021"
FT   CHAIN           22..133
FT                   /note="Lanmodulin"
FT                   /id="PRO_5002948339"
FT   DOMAIN          35..46
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000305|PubMed:30351021"
FT   DOMAIN          59..70
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000305|PubMed:30351021"
FT   DOMAIN          84..95
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000305|PubMed:30351021"
FT   DOMAIN          108..119
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000305|PubMed:30351021"
FT   BINDING         35
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         37
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         39
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         41
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         46
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         59
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         61
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         63
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         65
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         70
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         84
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         86
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         88
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         90
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         95
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         108
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         110
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         112
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         114
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   BINDING         119
FT                   /ligand="Nd(3+)"
FT                   /ligand_id="ChEBI:CHEBI:229785"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000269|PubMed:37259003,
FT                   ECO:0007744|PDB:8FNS"
FT   MUTAGEN         36
FT                   /note="P->A: The mutant protein shows altered metal-binding
FT                   properties, it is significantly more conformationally
FT                   sensitive to Ca(2+); when associated with A-60 and A-85 and
FT                   A-109."
FT                   /evidence="ECO:0000269|PubMed:30351021"
FT   MUTAGEN         60
FT                   /note="P->A: The mutant protein shows altered metal-binding
FT                   properties, it is significantly more conformationally
FT                   sensitive to Ca(2+); when associated with A-36 and A-85 and
FT                   A-109."
FT                   /evidence="ECO:0000269|PubMed:30351021"
FT   MUTAGEN         85
FT                   /note="P->A: The mutant protein shows altered metal-binding
FT                   properties, it is significantly more conformationally
FT                   sensitive to Ca(2+); when associated with A-36 and A-60 and
FT                   A-109."
FT                   /evidence="ECO:0000269|PubMed:30351021"
FT   MUTAGEN         109
FT                   /note="P->A: The mutant protein shows altered metal-binding
FT                   properties, it is significantly more conformationally
FT                   sensitive to Ca(2+); when associated with A-36 and A-60 and
FT                   A-85."
FT                   /evidence="ECO:0000269|PubMed:30351021"
FT   HELIX           24..27
FT                   /evidence="ECO:0007829|PDB:6MI5"
FT   HELIX           31..34
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   HELIX           44..58
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   STRAND          63..66
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   TURN            68..74
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   HELIX           77..83
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   STRAND          85..91
FT                   /evidence="ECO:0007829|PDB:6MI5"
FT   HELIX           93..107
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   STRAND          112..115
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   HELIX           117..121
FT                   /evidence="ECO:0007829|PDB:8FNS"
FT   HELIX           123..132
FT                   /evidence="ECO:0007829|PDB:8FNS"
SQ   SEQUENCE   133 AA;  13846 MW;  4DA0FAC96BB1639D CRC64;
     MAFRLSSAVL LAALVAAPAY AAPTTTTKVD IAAFDPDKDG TIDLKEALAA GSAAFDKLDP
     DKDGTLDAKE LKGRVSEADL KKLDPDNDGT LDKKEYLAAV EAQFKAANPD NDGTIDAREL
     ASPAGSALVN LIR
//
